Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01 is a lead clinical-stage candidate, like NCP-01 and CCP-01, is generated from the patient’s blood. The Company is engaged in providing treatment for ischemia, such as ischemic cardiomyopathy, angina, peripheral arterial disease including critical limb ischemia. The Company’s proprietary technology is a personalized regenerative therapy that is administered to a patient within seven days of the initial blood draw. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd., and PreCerv Inc.


TSXV:HEM - Post by User

Post by Pimpovishon Dec 29, 2020 4:08pm
281 Views
Post# 32193455

64.5 million traded at 3.5 cents average

64.5 million traded at 3.5 cents average

 


 

 

 

House Positions for C:HEM from 20201229 to 20201229
House Bought $Val Ave Sold $Val Ave Net $Net
2 RBC 9,226,179 336,649 0.036 3,542,765 125,722 0.035 5,683,414 -210,927
88 Credential 5,255,500 188,335 0.036 1,915,500 67,307 0.035 3,340,000 -121,028
124 Questrade 1,939,901 67,032 0.035 164,500 5,612 0.034 1,775,401 -61,420
19 Desjardins 1,715,484 61,317 0.036 782,500 27,727 0.035 932,984 -33,590
80 National Bank 1,143,253 41,011 0.036 322,200 12,484 0.039 821,053 -28,527
57 Interactive 1,423,855 50,967 0.036 1,118,000 35,880 0.032 305,855 -15,087
7 TD Sec 13,786,699 483,204 0.035 13,525,130 490,224 0.036 261,569 7,020
143 Pershing 200,000 6,000 0.03 0   200,000 -6,000
17 Integral 2,000 80 0.04 0   2,000 -80
28 BBS 2,000 80 0.04 0   2,000 -80
53 Morgan Stanley 91,900 3,665 0.04 90,000 2,700 0.03 1,900 -965
83 Mackie 150,000 6,000 0.04 183,000 5,490 0.03 -33,000 -510
79 CIBC 2,310,565 81,454 0.035 2,363,649 77,834 0.033 -53,084 -3,620
59 PI 17,623 598 0.034 980,512 33,091 0.034 -962,889 32,493
85 Scotia 3,061,864 115,221 0.038 4,162,769 141,174 0.034 -1,100,905 25,953
9 BMO Nesbitt 1,700,050 62,537 0.037 3,111,000 107,235 0.034 -1,410,950 44,698
22 Fidelity 31,600 1,046 0.033 1,500,000 55,000 0.037 -1,468,400 53,954
13 Instinet 1,437,000 46,435 0.032 3,190,000 114,775 0.036 -1,753,000 68,340
33 Canaccord 6,174,000 202,865 0.033 8,236,140 290,337 0.035 -2,062,140 87,472
1 Anonymous 14,834,992 496,784 0.033 16,904,800 586,521 0.035 -2,069,808 89,737
68 Leede 38,000 1,330 0.035 2,450,000 73,500 0.03 -2,412,000 72,170
TOTAL 64,542,465 2,252,610 0.035 64,542,465 2,252,613 0.035 0 3

<< Previous
Bullboard Posts
Next >>